Ed, Obviously ENTA had no part in the development of the HepC drugs, rather the ABBV really liked the ENTA CEO so decided to give ENTA share of the money from HepC drugv sales. /s
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.